azoxymethane has been researched along with resveratrol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caderni, G; Davit, A; Sarotto, I; Tessitore, L | 1 |
Birt, DF; Brummer, EC; Kineman, BD; Paiva, NL | 1 |
Chiou, YS; Ho, CT; Nagabhushanam, K; Pan, MH; Tsai, ML; Wang, YJ; Wu, CH | 1 |
Birt, DF; Boddicker, RL; Davis, JE; Spurlock, ME; Whitley, EM | 1 |
Bian, Z; Gou, X; Jia, W; Kou, F; Liao, W; Qiu, Y; Wang, X; Wei, H; Wu, J; Wu, T; Xie, G; Zhang, X; Zhang, Y; Zhou, M | 1 |
Gurocak, S; Karabulut, AB; Karabulut, E; Karadag, N; Ozgor, D; Ozkeles, N | 1 |
Bay Karabulut, A; Kurus, M; Otlu, O; Taslidere, E | 1 |
7 other study(ies) available for azoxymethane and resveratrol
Article | Year |
---|---|
Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Azoxymethane; bcl-2-Associated X Protein; Carcinogens; Cell Division; Colon; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Growth Inhibitors; Intestinal Mucosa; Male; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred F344; Rectum; Resveratrol; Stilbenes | 2000 |
Resveratrol from transgenic alfalfa for prevention of aberrant crypt foci in mice.
Topics: Animals; Azoxymethane; Body Weight; Chromatography, High Pressure Liquid; Colonic Neoplasms; Eating; Female; Glucosides; Lactase-Phlorizin Hydrolase; Medicago sativa; Mice; Plants, Genetically Modified; Precancerous Conditions; Resveratrol; Stilbenes | 2010 |
Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway.
Topics: Animals; Antioxidants; Azoxymethane; Colonic Neoplasms; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Resveratrol; Signal Transduction; Stilbenes | 2011 |
Low-dose dietary resveratrol has differential effects on colorectal tumorigenesis in adiponectin knockout and wild-type mice.
Topics: Adipocytes; Adiponectin; Animals; Azoxymethane; Caco-2 Cells; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dextran Sulfate; Dietary Fats; Dose-Response Relationship, Drug; Female; Humans; Insulin; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Resveratrol; Sex Factors; Stilbenes; Weight Gain | 2011 |
Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colorectal Neoplasms; Male; Metabolome; Precancerous Conditions; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2012 |
Preventive effects of resveratrol against azoxymethane induced damage in rat liver.
Topics: Animals; Antioxidants; Azoxymethane; Carcinogens; Female; Glutathione; Liver Diseases; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2013 |
Preventive effects of Resveratrol against azoxymethane-induced testis injury in rats.
Topics: Animals; Antioxidants; Azoxymethane; Carcinogens; Male; Oxidative Stress; Rats; Resveratrol; Seminiferous Tubules; Stilbenes; Testis; Testosterone | 2017 |